New rules bar unethical marketing by pharma companies
The government issued a directive instructing pharmaceutical industry associations to ensure "strict compliance" with the UCPMP 2024.
The government issued a directive instructing pharmaceutical industry associations to ensure "strict compliance" with the UCPMP 2024.
Revenue growth will be driven by steady performance across key markets — the U.S. and India — and some recovery in growth in the European market.
A majority of pharma stocks reported double digit negative returns, while the overall market (BSE Sensex) delivered a 9% plus return.
NGO FMRAI tells SC that DOLO drug maker distributed freebies worth ₹1,000 crore to doctors for prescribing its 650 mg dosages